APS Support UK/X
Aug 7, 2025, 00:59
Hydroxychloroquine in APS: Anti-Inflammatory and Antithrombotic Effects Supported by Recent Evidence
APS Support UK has shared a post on X:
“ NEW REVIEW | Hydroxychloroquine in APS
- HCQ shows anti-inflammatory/thrombotic effects
- Deacreases platelet aggregation, NET formation, complement (C3a/C5a)
- Supports use in OAPS ( higher birth rate in treated vs untreated: 67% vs 57%).”
Read the full article here.
Title: The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review
Authors: Ilker Ates, Hilal Sahin, Lalu Muhammad Irham, Serkan Yilmaz, Sinan Suzen

Stay updated with the latest scientific advances with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome